| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 31.42B | 32.26B | 26.08B | 30.12B | 26.66B | 31.69B |
| Gross Profit | 3.02B | 2.98B | 1.72B | 3.47B | 2.22B | 2.39B |
| EBITDA | 1.08B | 1.13B | 357.00M | 2.01B | 864.00M | 1.12B |
| Net Income | 555.00M | 611.00M | 75.00M | 1.32B | 355.00M | 651.00M |
Balance Sheet | ||||||
| Total Assets | 25.76B | 27.49B | 26.30B | 26.78B | 25.84B | 25.20B |
| Cash, Cash Equivalents and Short-Term Investments | 14.78B | 14.10B | 13.94B | 12.39B | 10.11B | 9.60B |
| Total Debt | 1.30B | 1.33B | 1.29B | 1.27B | 1.54B | 1.55B |
| Total Liabilities | 11.38B | 11.96B | 11.05B | 11.21B | 11.28B | 10.80B |
| Stockholders Equity | 14.38B | 15.52B | 15.24B | 15.57B | 14.55B | 14.40B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 579.00M | 1.97B | 2.72B | 754.00M | 185.00M |
| Operating Cash Flow | 0.00 | 900.00M | 2.01B | 2.91B | 1.32B | 194.00M |
| Investing Cash Flow | 0.00 | -362.00M | -97.00M | -21.00M | -584.00M | -109.00M |
| Financing Cash Flow | 0.00 | -371.00M | -367.00M | -601.00M | -230.00M | -357.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥15.54B | 5.70 | ― | 1.60% | 22.31% | 101.45% | |
71 Outperform | ¥18.33B | 10.67 | ― | 2.87% | -1.39% | -4.43% | |
67 Neutral | ¥16.36B | 12.39 | ― | 3.68% | 5.82% | -22.14% | |
66 Neutral | ¥15.94B | 8.28 | ― | 1.01% | 17.09% | 43.01% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
59 Neutral | ¥15.20B | 22.90 | ― | 5.36% | -3.19% | 109.84% | |
54 Neutral | ¥15.34B | 65.15 | ― | 2.54% | 5.89% | -30.27% |